TrialPLoS medicine2023

Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial.

Xinlei Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.